— Know what they know.
Not Investment Advice

RNAC NASDAQ

Cartesian Therapeutics, Inc.
1W: +6.9% 1M: -20.8% 3M: -19.9% YTD: +1.3% 1Y: -38.0% 3Y: -82.2% 5Y: -94.9%
$6.85
+0.99 (+16.89%)
Pre-Market: $7.17 (+0.32, +4.60%)
Weekly Expected Move ±14.0%
$4 $5 $6 $7 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $201.3M mcap · 11M float · 1.80% daily turnover · Short 51% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
33.7 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 30.2%
Cost Advantage
34
Intangibles
37
Switching Cost
31
Network Effect
39
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. RNAC has No discernible competitive edge (33.7/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 30.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$25
Low
$25
Avg Target
$25
High
Based on 1 analyst since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$25.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-12 H.C. Wainwright $45 $25 -20 +193.1% $8.53
2026-03-09 Cantor Fitzgerald Initiated $16 +77.4% $9.02
2024-08-09 H.C. Wainwright Mitchell Kapoor Initiated $45 +249.7% $12.87
2024-07-03 Canaccord Genuity John Newman Initiated $43 +172.7% $15.77
2024-05-24 Mizuho Securities Uy Ear Initiated $40 +57.1% $25.46

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Jun 09, 2026
DCF
4
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. RNAC receives an overall rating of C+. Strongest factors: DCF (4/5), ROE (5/5). Areas of concern: ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-03-09 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

8 Grade D
Profitability
20
Balance Sheet
53
Earnings Quality
18
Growth
12
Value
23
Momentum
20
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. RNAC scores highest in Balance Sheet (53/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-3.94
Distress Zone
Piotroski F-Score
1/9
Beneish M-Score
9.09
Possible Manipulator
Ohlson O-Score
-0.80
Bankruptcy prob: 31.0%
Moderate
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
OCF/NI: 0.48x
Accruals: -21.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. RNAC scores -3.94, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. RNAC scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. RNAC's score of 9.09 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. RNAC's implied 31.0% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. RNAC receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.21x
PEG
0.01x
P/S
113.39x
P/B
-1.24x
P/FCF
-2.13x
P/OCF
EV/EBITDA
-0.78x
EV/Revenue
29.69x
EV/EBIT
-0.77x
EV/FCF
-0.68x
Earnings Yield
-91.90%
FCF Yield
-46.85%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. RNAC currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.943
NI / EBT
×
Interest Burden
2.351
EBT / EBIT
×
EBIT Margin
-38.566
EBIT / Rev
×
Asset Turnover
0.005
Rev / Assets
×
Equity Multiplier
-5.498
Assets / Equity
=
ROE
228.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. RNAC's ROE of 228.2% is driven by Asset Turnover (0.005), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.94 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.85
Median 1Y
$3.14
5th Pctile
$0.77
95th Pctile
$13.14
Ann. Volatility
92.9%
Analyst Target
$25.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Carsten Brunn, Ph.D.
President and Chief Executive Officer
$674,000 $973,475 $4,329,868
Metin Kurtoglu, M.D.,
Ph.D. Former Chief Technology Officer
$163,494 $775,931 $2,474,034
Christopher Jewell, Ph.D.
Former Chief Scientific Officer
$390,665 $375,046 $2,015,707
Blaine Davis Financial
ancial Officer
$475,860 $372,460 $1,949,927
Milos Miljkovic, M.D.
Chief Medical Officer
$439,000 $321,670 $1,657,535

CEO Pay Ratio

10:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $4,329,868
Avg Employee Cost (SGA/emp): $419,573
Employees: 75

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
75
+13.6% YoY
Revenue / Employee
$37,293
Rev: $2,797,000
Profit / Employee
$-1,737,360
NI: $-130,302,000
SGA / Employee
$419,573
Avg labor cost proxy
R&D / Employee
$773,787
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 9.4% 11.1% -11.4% 12.3% 14.1% 18.5% 60.8% -25.9% -60.2% -62.2% 1.3% 1.5% 1.3% 1.4% 34.6% 17.1% 16.2% 21.5% 2.0% 2.3% 2.28%
ROA -34.1% -40.3% -15.8% 17.0% 19.5% 25.7% 21.7% -9.2% -21.5% -22.2% -93.3% -1.1% -97.5% -1.0% -20.9% -10.4% -9.8% -13.0% -35.6% -41.5% -41.50%
ROIC 18.4% 10.8% 5.2% -12.0% -25.3% -38.8% -5.2% 4.1% 13.1% 16.2% 13.5% 12.7% 7.6% 8.4% 16.9% 20.2% 33.8% 35.2% 28.7% 30.2% 30.22%
ROCE -50.9% -41.4% -7.8% 53.1% 57.7% 50.8% 26.8% -7.1% -27.0% -31.0% -1.0% -1.0% -88.4% -93.1% -8.2% -10.3% -9.7% -12.6% -22.7% -24.3% -24.32%
Gross Margin 1.0% 1.0% 1.0% 98.1% 98.7% 97.4% 96.4% -2.1% -2.4% -98.5% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% -27.3% 1.0% 1.0% 1.00%
Operating Margin 2.3% -8.1% 13.6% 31.7% 35.3% -7.7% -50.6% -3.1% -3.6% -2.0% -4.4% -2.3% 41.1% -45.4% 35.2% -19.9% -73.2% -46.6% -23.2% -339.7% -339.73%
Net Margin 23.2% -73.3% 40.9% 84.6% 21.9% -38.1% 35.1% -3.6% -2.2% -1.4% -21.5% -9.7% 41.4% -62.5% 13.5% -16.1% 53.3% -79.4% -97.8% -502.3% -502.33%
EBITDA Margin 29.8% -3.0% 44.8% 88.6% 25.0% -33.2% 41.8% -3.1% -3.5% -2.0% -23.8% -2.3% 41.7% -61.7% 12.5% -18.8% 55.3% -78.1% -23.2% -339.7% -339.73%
FCF Margin 82.6% -55.4% -72.2% -57.0% -52.8% -42.4% -29.6% -35.6% -55.3% -1.2% -2.0% -2.3% -1.2% -1.0% -84.2% -1.2% -43.4% -63.2% -28.4% -43.6% -43.59%
OCF Margin 85.0% -53.9% -71.0% -55.6% -52.0% -41.4% -28.6% -34.5% -53.7% -1.2% -2.0% -2.3% -1.2% -83.4% -60.8% -90.3% -33.1% -58.0% -26.4% -41.1% -41.11%
ROA 3Y Avg snapshot only -47.85%
ROIC Economic snapshot only 63.50%
Cash ROA snapshot only -24.62%
NOPAT Margin snapshot only -40.64%
Pretax Margin snapshot only -90.69%
R&D / Revenue snapshot only 35.39%
SGA / Revenue snapshot only 17.05%
SBC / Revenue snapshot only 5.88%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -9.34 -8.98 -14.62 5.52 6.13 6.01 4.62 -14.15 -4.90 -4.54 -0.49 -0.41 -2.09 -1.41 -5.99 -8.91 -7.58 -5.54 -1.44 -1.09 -1.212
P/S Ratio 8.92 7.14 4.41 1.41 1.52 2.02 1.48 2.58 3.53 4.75 4.11 4.08 8.88 7.22 11.92 9.99 267.82 243.58 66.95 93.05 113.388
P/B Ratio -23.44 -26.61 16.67 6.79 8.64 11.13 1.74 2.27 1.83 1.75 -0.24 -0.24 -1.09 -0.79 -68.21 -50.19 -40.40 -39.07 -1.48 -1.31 -1.242
P/FCF 10.80 -12.89 -6.11 -2.48 -2.89 -4.77 -4.98 -7.25 -6.38 -4.09 -2.08 -1.79 -7.38 -7.15 -14.16 -8.44 -6.17 -3.86 -2.36 -2.13 -2.135
P/OCF 10.50
EV/EBITDA -7.72 -11.47 -58.03 1.23 1.93 3.40 1.67 -14.18 -2.06 -1.59 -0.17 -0.16 -1.99 -1.28 -8.14 -3.56 -2.02 -1.37 -1.22 -0.78 -0.783
EV/Revenue 6.74 5.60 3.32 0.56 0.80 1.27 0.60 1.41 1.54 1.95 1.58 1.53 7.66 5.84 6.82 4.18 74.23 61.52 26.74 29.69 29.688
EV/EBIT -7.46 -10.83 -41.11 1.29 2.01 3.55 1.77 -11.57 -1.98 -1.54 -0.17 -0.16 -1.98 -1.27 -7.87 -3.38 -1.90 -1.29 -1.17 -0.77 -0.770
EV/FCF 8.16 -10.11 -4.60 -0.97 -1.51 -3.01 -2.04 -3.96 -2.79 -1.68 -0.80 -0.67 -6.37 -5.79 -8.10 -3.53 -1.71 -0.97 -0.94 -0.68 -0.681
Earnings Yield -10.7% -11.1% -6.8% 18.1% 16.3% 16.6% 21.6% -7.1% -20.4% -22.0% -2.1% -2.4% -47.8% -70.7% -16.7% -11.2% -13.2% -18.1% -69.6% -91.9% -91.90%
FCF Yield 9.3% -7.8% -16.4% -40.3% -34.6% -20.9% -20.1% -13.8% -15.7% -24.4% -48.0% -55.9% -13.6% -14.0% -7.1% -11.8% -16.2% -25.9% -42.4% -46.8% -46.85%
PEG Ratio snapshot only 0.006
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.86 1.86 2.00 2.00 2.00 2.00 5.91 5.91 5.91 5.91 1.33 1.33 1.33 1.33 9.43 9.43 9.43 9.43 8.65 8.65 8.655
Quick Ratio 1.86 1.86 2.00 2.00 2.00 2.00 5.91 5.91 5.91 5.91 1.33 1.33 1.33 1.33 9.43 9.43 9.43 9.43 8.65 8.65 8.655
Debt/Equity -1.96 -1.96 1.57 1.57 1.57 1.57 0.40 0.40 0.40 0.40 -0.02 -0.02 -0.02 -0.02 -2.06 -2.06 -2.06 -2.06 -0.10 -0.10 -0.100
Net Debt/Equity -4.12 -4.12 -4.12 -4.12 -1.03 -1.03 -1.03 -1.03
Debt/Assets 0.21 0.21 0.22 0.22 0.22 0.22 0.23 0.23 0.23 0.23 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.04 0.04 0.043
Debt/EBITDA -0.86 -1.08 -7.24 0.72 0.67 0.76 0.95 -4.62 -1.04 -0.89 -0.04 -0.05 -0.05 -0.05 -0.43 -0.35 -0.37 -0.29 -0.21 -0.19 -0.188
Net Debt/EBITDA 2.50 3.15 19.05 -1.91 -1.76 -2.00 -2.41 11.77 2.65 2.28 0.27 0.27 0.32 0.30 6.09 4.95 5.28 4.05 1.83 1.67 1.672
Interest Coverage -17.08 -12.19 -2.42 16.37 17.77 15.15 12.47 -3.21 -12.00 -12.00 -87.10 -119.36 -164.43
Equity Multiplier -9.19 -9.19 7.10 7.10 7.10 7.10 1.77 1.77 1.77 1.77 -0.69 -0.69 -0.69 -0.69 -63.96 -63.96 -63.96 -63.96 -2.35 -2.35 -2.348
Cash Ratio snapshot only 8.378
Cash to Debt snapshot only 9.872
FCF to Debt snapshot only -6.104
Defensive Interval snapshot only 573.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.36 0.51 0.52 0.66 0.78 0.76 0.68 0.51 0.30 0.21 0.11 0.11 0.23 0.20 0.11 0.09 0.00 0.00 0.01 0.00 0.005
Inventory Turnover
Receivables Turnover 7.74 10.98 9.93 12.61 14.90 14.46 11.21 8.37 4.93 3.49 3.31 3.29 6.88 6.10 11.54 10.14 0.30 0.32 2.82 1.79 1.787
Payables Turnover 0.00 0.00 0.00 1.93 3.42 5.04 8.47 75.07 139.08 185.24 28.51 17.76 7.50 0.00 0.00 0.00 0.00 7.44 16.24 16.24 16.240
DSO 47 33 37 29 25 25 33 44 74 104 110 111 53 60 32 36 1199 1128 130 204 204.3 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 189 107 72 43 5 3 2 13 21 49 49 22 22 22.5 days
Cash Conversion Cycle -160 -82 -47 -10 39 71 103 98 90 4 1079 107 182 181.8 days
Fixed Asset Turnover snapshot only 0.100
Cash Velocity snapshot only 0.014
Capital Intensity snapshot only 166.992
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 6.1% 4.9% 4.1% 2.9% 1.7% 84.7% 30.2% -23.4% -61.9% -72.1% -76.5% -68.7% 11.1% 38.8% 49.6% 31.9% -98.1% -97.7% -92.8% -94.8% -94.81%
Net Income 36.0% 21.9% 62.7% 1.4% 1.7% 1.8% 2.4% -1.5% -2.1% -1.9% -7.2% -15.9% -5.6% -5.8% 64.8% 85.0% 84.2% 80.4% -68.3% -3.0% -2.96%
EPS 48.8% 40.5% 70.9% 1.3% 1.5% 1.6% 2.1% -1.4% -2.1% -1.9% -6.8% -15.0% -88.4% -62.7% 93.0% 96.9% 89.4% 83.8% -67.9% -2.8% -2.82%
FCF 1.8% -2.3% -2.8% -2.8% -2.7% -41.3% 46.6% 52.3% 60.0% 23.7% -56.5% -1.0% -1.4% -20.8% 36.2% 31.5% 31.6% -42.3% -1.4% -91.4% -91.37%
EBITDA 38.7% 49.7% 92.7% 1.7% 2.3% 2.4% 9.2% -1.2% -1.7% -1.9% -7.1% -28.3% -4.7% -4.2% 86.7% 83.3% 81.9% 77.7% -88.7% -67.5% -67.49%
Op. Income 52.4% 73.0% 91.9% 1.3% 1.9% 2.6% 4.2% -2.1% -2.8% -3.2% -6.9% -4.6% -4.0% 8.7% 49.2% 35.6% -79.6% -71.0% -97.5% -74.1% -74.14%
OCF Growth snapshot only -1.36%
Asset Growth snapshot only -31.86%
Debt Growth snapshot only -9.35%
Shares Change snapshot only 3.68%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 9.2% 14.8% 3.6% 3.9% 4.2% 4.1% 1.6% 1.3% 94.1% 45.1% 16.1% -2.1% 4.6% -10.6% -23.0% -31.9% -80.0% -79.4% -70.7% -72.2% -72.21%
Revenue 5Y 88.0% 85.4% 70.0% 77.5% 98.5% 1.1% 2.5% 3.1% 3.1% 3.6% 95.8% 95.2% 1.3% 1.2% 42.3% 38.7% -31.2% -37.3% -30.0% -42.3% -42.26%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 9.2% 14.8% 3.6% 3.9% 4.2% 4.1% 1.5% 1.1% 18.7% -4.6% -10.6% -23.0% -31.7% -79.9%
Gross Profit 5Y 88.0% 85.4% 70.0% 77.3% 98.1% 1.1% 2.5% 2.9% 2.0% 1.1% 1.2% 42.3% 38.7% -31.2%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 17.8% 17.8% 53.2% 53.2% 53.2% 53.2% 18.5% 18.5% 18.5% 18.5% 22.6% 22.6% 22.6% 22.6% 39.6% 39.6% 39.6% 39.6% 21.3% 21.3% 21.35%
Assets 5Y 31.0% 31.0% 12.4% 12.4% 12.4% 12.4% 10.4% 10.4% 10.4% 10.4% 47.0% 47.0% 47.0% 47.0% 34.3% 34.3% 34.3% 34.3% 12.4% 12.4% 12.37%
Equity 3Y 1.2% 1.2% 1.2% 1.2%
Book Value 3Y 49.9% 79.2% 80.4% 85.0%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.47 0.48 0.50 0.54 0.62 0.70 0.78 0.71 0.46 0.36 0.27 0.20 0.22 0.11 0.02 0.00 0.01 0.03 0.06 0.17 0.168
Earnings Stability 0.29 0.29 0.00 0.22 0.45 0.47 0.64 0.47 0.43 0.37 0.08 0.16 0.17 0.18 0.10 0.06 0.07 0.10 0.19 0.18 0.184
Margin Stability 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.89 0.59 0.09 0.00 0.28 0.58 0.09 0.00 0.28 0.58 0.00 0.00 0.00 0.000
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.86 0.91 0.50 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend
Gross Margin Trend 0.00 0.00 0.00 -0.01 -0.01 -0.01 -0.02 -0.24 -0.77 -1.44 -1.89 -1.06 0.15 0.73 0.96 0.72 0.51 -11.01 -3.63 -6.62 -6.615
FCF Margin Trend 35.01 26.09 2.11 2.05 2.66 -1.41 -0.96 -0.68 -0.70 -0.67 -1.47 -1.81 -0.66 -0.22 0.29 0.13 -42.51 -62.07 -26.98 -41.86 -41.861
Sustainable Growth Rate 12.3% 14.1% 18.5% 60.8%
Internal Growth Rate 20.5% 24.2% 34.5% 27.7%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -0.89 0.68 2.35 -2.17 -2.09 -1.23 -0.89 1.89 0.75 1.10 0.23 0.23 0.27 0.16 0.31 0.81 0.94 1.32 0.57 0.48 0.481
FCF/OCF 0.97 1.03 1.02 1.03 1.02 1.02 1.04 1.03 1.03 1.01 1.00 1.01 1.04 1.21 1.38 1.31 1.31 1.09 1.07 1.06 1.060
FCF/Net Income snapshot only 0.510
CapEx/Revenue 2.4% 1.5% 1.3% 1.4% 0.8% 1.0% 1.1% 1.1% 1.6% 1.0% 0.8% 2.6% 4.2% 17.6% 23.4% 28.0% 10.3% 5.2% 1.9% 2.5% 2.48%
CapEx/Depreciation snapshot only 3.687
Accruals Ratio -0.64 -0.13 0.21 0.54 0.60 0.57 0.41 0.08 -0.05 0.02 -0.72 -0.83 -0.71 -0.87 -0.15 -0.02 -0.01 0.04 -0.15 -0.22 -0.215
Sloan Accruals snapshot only -0.220
Cash Flow Adequacy snapshot only -16.561
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -9.4% -6.4% -13.8% -21.4% -31.3% -23.9% -23.8% -17.5% -0.2% 0.0% 0.0% 0.0% -0.0% -36.0% -26.9% -36.4% -45.2% -0.1% -0.1% -9.5% -9.49%
Total Shareholder Return -9.4% -6.4% -13.8% -21.4% -31.3% -23.9% -23.8% -17.5% -0.2% 0.0% 0.0% 0.0% -0.0% -36.0% -26.9% -36.4% -45.2% -0.1% -0.1% -9.5% -9.49%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.42 2.64 0.63 0.67 1.00 1.02 0.96 0.98 0.99 0.92 0.93 0.92 0.93 1.00 1.01 1.01 1.01 0.93 0.94 0.943
Interest Burden (EBT/EBIT) 1.06 1.08 1.41 0.94 0.94 0.93 0.92 1.56 0.94 0.83 0.97 1.13 1.19 1.20 2.29 0.90 0.90 0.92 2.18 2.35 2.351
EBIT Margin -0.90 -0.52 -0.08 0.43 0.40 0.36 0.34 -0.12 -0.78 -1.26 -9.49 -9.33 -3.87 -4.60 -0.87 -1.24 -39.13 -47.54 -22.83 -38.57 -38.566
Asset Turnover 0.36 0.51 0.52 0.66 0.78 0.76 0.68 0.51 0.30 0.21 0.11 0.11 0.23 0.20 0.11 0.09 0.00 0.00 0.01 0.00 0.005
Equity Multiplier -27.58 -27.58 72.05 72.05 72.05 72.05 2.80 2.80 2.80 2.80 -1.36 -1.36 -1.36 -1.36 -1.66 -1.66 -1.66 -1.66 -5.50 -5.50 -5.498
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-13.43 $-13.90 $-6.69 $6.69 $6.41 $8.19 $7.33 $-2.95 $-6.85 $-7.01 $-42.49 $-47.08 $-12.91 $-11.40 $-2.99 $-1.48 $-1.37 $-1.85 $-5.02 $-5.65 $-5.65
Book Value/Share $-5.35 $-4.69 $5.87 $5.44 $4.55 $4.42 $19.45 $18.36 $18.34 $18.18 $-85.14 $-81.30 $-24.74 $-20.50 $-0.26 $-0.26 $-0.26 $-0.26 $-4.86 $-4.70 $-5.52
Tangible Book/Share $-5.35 $-4.69 $5.87 $5.44 $4.55 $4.42 $19.45 $18.36 $18.34 $18.18 $-123.58 $-118.02 $-35.91 $-29.76 $-7.93 $-7.94 $-7.77 $-7.91 $-6.71 $-6.49 $-6.49
Revenue/Share $14.06 $17.48 $22.16 $26.09 $25.78 $24.32 $22.96 $16.18 $9.52 $6.69 $5.03 $4.78 $3.04 $2.23 $1.50 $1.32 $0.04 $0.04 $0.11 $0.07 $0.07
FCF/Share $11.61 $-9.68 $-16.01 $-14.88 $-13.60 $-10.31 $-6.80 $-5.75 $-5.27 $-7.77 $-9.93 $-10.90 $-3.66 $-2.25 $-1.26 $-1.56 $-1.68 $-2.65 $-3.06 $-2.88 $-2.88
OCF/Share $11.95 $-9.42 $-15.73 $-14.52 $-13.40 $-10.06 $-6.56 $-5.58 $-5.11 $-7.70 $-9.90 $-10.77 $-3.53 $-1.86 $-0.91 $-1.19 $-1.28 $-2.43 $-2.85 $-2.72 $-2.72
Cash/Share $41.20 $36.13 $33.36 $30.92 $25.87 $25.13 $27.90 $26.33 $26.32 $26.08 $14.88 $14.21 $4.32 $3.58 $8.21 $8.21 $8.04 $8.18 $4.82 $4.66 $4.42
EBITDA/Share $-12.26 $-8.54 $-1.27 $11.75 $10.63 $9.12 $8.31 $-1.61 $-7.13 $-8.24 $-47.56 $-44.49 $-11.72 $-10.22 $-1.26 $-1.55 $-1.42 $-1.89 $-2.37 $-2.50 $-2.50
Debt/Share $10.50 $9.21 $9.19 $8.52 $7.13 $6.92 $7.86 $7.42 $7.41 $7.35 $2.12 $2.02 $0.62 $0.51 $0.54 $0.54 $0.53 $0.54 $0.49 $0.47 $0.47
Net Debt/Share $-30.70 $-26.92 $-24.17 $-22.40 $-18.74 $-18.21 $-20.04 $-18.91 $-18.90 $-18.74 $-12.76 $-12.18 $-3.71 $-3.07 $-7.67 $-7.67 $-7.51 $-7.64 $-4.33 $-4.19 $-4.19
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -3.943
Altman Z-Prime snapshot only -7.656
Piotroski F-Score 5 4 3 4 4 4 5 2 3 2 3 3 3 3 5 5 4 3 1 1 1
Beneish M-Score 0.33 -0.03 1.98 1.48 1.08 -0.41 -0.28 0.46 -2.60 7.09 5.69 10.37 15.89 -4.38 -13.88 -3.58 9.09 9.093
Ohlson O-Score snapshot only -0.799
Net-Net WC snapshot only $-10.92
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 20.00 20.00 21.69 48.19 49.16 49.44 61.28 31.54 31.37 31.64 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 32
Sector Credit Rank snapshot only 30

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms